medpace" class="internal-tag-link">Medpace Holdings (NASDAQ:MEDP) shareholders approved several amendments to the company's charter and bylaws at the 2026 Annual Meeting. Supermajority voting requirements were removed.
Shareholders also approved changes allowing holders of at least 25% voting power for one year to call special meetings. Five directors were elected, including Brian T. Carley.
Deloitte & Touche was ratified as independent auditor. Executive compensation received advisory approval. Shareholders favored annual advisory votes on pay.












